QQQ   434.91 (-0.61%)
AAPL   180.69 (-1.06%)
MSFT   406.77 (-0.17%)
META   484.21 (-0.58%)
GOOGL   135.99 (-2.08%)
AMZN   173.02 (-0.30%)
TSLA   201.59 (+0.93%)
NVDA   781.07 (-0.75%)
NIO   5.45 (-5.71%)
AMD   176.22 (-1.00%)
BABA   74.79 (-3.72%)
T   16.98 (+0.89%)
F   12.39 (+3.25%)
MU   89.54 (-2.51%)
CGC   3.39 (-3.97%)
GE   155.52 (+0.99%)
DIS   110.66 (+1.13%)
AMC   4.88 (+1.46%)
PFE   27.15 (+0.97%)
PYPL   60.44 (+0.47%)
XOM   104.43 (+0.38%)
QQQ   434.91 (-0.61%)
AAPL   180.69 (-1.06%)
MSFT   406.77 (-0.17%)
META   484.21 (-0.58%)
GOOGL   135.99 (-2.08%)
AMZN   173.02 (-0.30%)
TSLA   201.59 (+0.93%)
NVDA   781.07 (-0.75%)
NIO   5.45 (-5.71%)
AMD   176.22 (-1.00%)
BABA   74.79 (-3.72%)
T   16.98 (+0.89%)
F   12.39 (+3.25%)
MU   89.54 (-2.51%)
CGC   3.39 (-3.97%)
GE   155.52 (+0.99%)
DIS   110.66 (+1.13%)
AMC   4.88 (+1.46%)
PFE   27.15 (+0.97%)
PYPL   60.44 (+0.47%)
XOM   104.43 (+0.38%)
QQQ   434.91 (-0.61%)
AAPL   180.69 (-1.06%)
MSFT   406.77 (-0.17%)
META   484.21 (-0.58%)
GOOGL   135.99 (-2.08%)
AMZN   173.02 (-0.30%)
TSLA   201.59 (+0.93%)
NVDA   781.07 (-0.75%)
NIO   5.45 (-5.71%)
AMD   176.22 (-1.00%)
BABA   74.79 (-3.72%)
T   16.98 (+0.89%)
F   12.39 (+3.25%)
MU   89.54 (-2.51%)
CGC   3.39 (-3.97%)
GE   155.52 (+0.99%)
DIS   110.66 (+1.13%)
AMC   4.88 (+1.46%)
PFE   27.15 (+0.97%)
PYPL   60.44 (+0.47%)
XOM   104.43 (+0.38%)
QQQ   434.91 (-0.61%)
AAPL   180.69 (-1.06%)
MSFT   406.77 (-0.17%)
META   484.21 (-0.58%)
GOOGL   135.99 (-2.08%)
AMZN   173.02 (-0.30%)
TSLA   201.59 (+0.93%)
NVDA   781.07 (-0.75%)
NIO   5.45 (-5.71%)
AMD   176.22 (-1.00%)
BABA   74.79 (-3.72%)
T   16.98 (+0.89%)
F   12.39 (+3.25%)
MU   89.54 (-2.51%)
CGC   3.39 (-3.97%)
GE   155.52 (+0.99%)
DIS   110.66 (+1.13%)
AMC   4.88 (+1.46%)
PFE   27.15 (+0.97%)
PYPL   60.44 (+0.47%)
XOM   104.43 (+0.38%)
OTCMKTS:FLACU

Frazier Lifesciences Acquisition (FLACU) Stock Price, News & Analysis

$9.50
+0.23 (+2.48%)
(As of 11/22/2022)
Today's Range
$8.07
$10.80
50-Day Range
$9.50
$9.50
52-Week Range
$8.07
$10.80
Volume
18,300 shs
Average Volume
13,949 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Frazier Lifesciences Acquisition

Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

FLACU Stock Price History

FLACU Stock News Headlines

Frazier Lifesciences Acquisition Corporation (FLACU)
Detecting Cancer in Mere Seconds: Early Investment Opportunity
A revolutionary cancer diagnostic tool is likely to come to fruition with anticipated FDA approval expected in just months. With the ability to detect cancer's "molecular fingerprint" in just seconds, it also offers far superior accuracy to current detection methods and reduces the need for invasive biopsies.
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
Frazier Lifesciences Acquisition Corp. Cl A
See More Headlines
Receive FLACU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Frazier Lifesciences Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Shell Companies
Sub-Industry
N/A
Current Symbol
OTCMKTS:FLACU
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. James N. Topper M.D. (Age 60)
    Ph.D., CEO & Chairman
  • Mr. David J. Topper (Age 64)
    CFO & Director
  • Mr. Gordon Empey J.D. (Age 53)
    VP & Gen. Counsel














FLACU Stock Analysis - Frequently Asked Questions

How have FLACU shares performed in 2024?

Frazier Lifesciences Acquisition's stock was trading at $9.50 at the beginning of the year. Since then, FLACU stock has increased by 0.0% and is now trading at $9.50.
View the best growth stocks for 2024 here
.

How do I buy shares of Frazier Lifesciences Acquisition?

Shares of FLACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:FLACU) was last updated on 2/28/2024 by MarketBeat.com Staff